Comparison of Expression of p53 and bcl-2 Markers in Oral Lichen Planus and Oral Squamous Cell Carcinoma
Authors
Abstract:
Background and Aim: It has been suggested that oral lichen planus (OLP) can be a potential premalignant lesion. Reports are also available on the role of bcl-2 and p53 proteins in malignant transformation of OLP into oral squamous cell carcinoma (OSCC). Due to controversies in these reports, the present study aimed to compare the expression of p53 and bcl-2 markers in OLP and OSCC. Materials and Methods: In this experimental study, immunohistochemical (IHC) staining was performed on erosive OLP and well-differentiated OSCC samples using bcl-2 and p53 antibodies. One-thousand cells per slide were counted, and the results were reported as percentages. The results were scored, and Mann-Whitney U test was used to compare staining grades in the two lesions. Results: Twenty-two OLP and 25 OSCC samples with a mean age of 49.3±15.8 years were evaluated. Bcl-2 expression was reported to be 16.27±8.95% in OLP and 16.4±22.9% in OSCC. Expression of p53 was 30.86±28.26% in OLP and 49.6±29.6% in OSCC. The difference in bcl-2 expression between the two lesions was not significant (P=0.266), whereas this difference was significant for p53 expression (P=0.02). The correlation coefficient between these two markers was reported to be 0.45 in OSCC and 0.1 in OLP. Conclusion: According to the results, there was a significant difference in p53 expression between OLP and OSCC samples, whereas this difference was not significant for bcl-2. There was no significant association between the expressions of these two markers in the samples. Therefore, there does not seem to be a high malignancy potential for the studied OLP samples.
similar resources
Assessment of Bax and Bcl-2 Immunoexpression in Patients with Oral Lichen Planus and Oral Squamous Cell Carcinoma
Lichen planus (LP) is a chronic inflammatory disease of probable immune-based etiology. The pathogenesis of LP is unclear, but apoptotic changes in epidermal (epithelial) cells have been reported. Destruction of the basal cell layer is observed and many changes in cell proliferation, cell repair and cell death occur in the injured mucosal epithelium. The aim of this study was to evaluate and co...
full textP53 and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma
OBJECTIVE The aim of this study was to determine by immunohistochemistry the presence and significance of p53 and bcl-2 proteins in oral lichen planus (OLP) and oral squamous cell carcinoma (OSCC). STUDY DESIGN We used 21 cases diagnosed as OLP 16 diagnosed as OSCC and four normal gingival biopsies taken from healthy patients were used as controls. Slides were processed for immunohistochemist...
full textassessment of bax and bcl-2 immunoexpression in patients with oral lichen planus and oral squamous cell carcinoma
lichen planus (lp) is a chronic inflammatory disease of probable immune-based etiology. the pathogenesis of lp is unclear, but apoptotic changes in epidermal (epithelial) cells have been reported. destruction of the basal cell layer is observed and many changes in cell proliferation, cell repair and cell death occur in the injured mucosal epithelium. the aim of this study was to evaluate and co...
full textVascular Endothelial Growth Factor in Serum and Saliva of Oral Lichen Planus and Oral Squamous Cell Carcinoma Patients
Background:Oral lichen planus (OLP) is considered as a potentially malignant disorder and vascular endothelial growth factor (VEGF) may play a key role in cancer development. The aim of this study was to compare serum and saliva VEGF among patients with OLP, oral squamous cell carcinoma (OSCC) and a healthy control group. Methods:A cross sectional study was pe...
full textstudy of p21 expression in oral lichen planus and oral squamous cell carcinoma by immunohistochemical technique
statement of the problem: lichen planus is a mucocutaneous disease that is relatively common in middle aged individuals. some studies have shown that oral lichen planus has a potential to progress to squamous cell carcinoma.p21 is a cyclin-dependent kinase inhibitor that regulates the cell cycle, thus it acts as an inhibitor in cell proliferation. purpose: this study was aimed to evaluate and c...
full textSerum and saliva collagenase-3 (MMP-13) in patients with oral lichen planus and oral squamous cell carcinoma
Background: Oral lichen planus (OLP) has been classified as a pre-malignant condition. Matrix metalloproteinase-13 (MMP-13) or collagenase-3 may play a key role in cancer development. The aim of this study was to compare serum and saliva MMP-13 between patients with oral lichen planus (OLP) and oral squamous cell carcinoma (OSCC). Methods : This cross sectional study was performed on 30 pat...
full textMy Resources
Journal title
volume 3 issue 2
pages 37- 45
publication date 2018-04
By following a journal you will be notified via email when a new issue of this journal is published.
Hosted on Doprax cloud platform doprax.com
copyright © 2015-2023